[HTML][HTML] Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Y Tokunaga, Y Osawa, T Ohtsuki, Y Hayashi… - Scientific reports, 2017 - nature.com
Chronic hepatitis C virus (HCV) infection is one of the major causes of serious liver
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
[HTML][HTML] Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Y Tokunaga, Y Osawa, T Ohtsuki, Y Hayashi… - Scientific …, 2017 - ncbi.nlm.nih.gov
Chronic hepatitis C virus (HCV) infection is one of the major causes of serious liver
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
[PDF][PDF] Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Y Tokunaga, Y Osawa, T Ohtsuki, Y Hayashi, K Yamaji… - cyberleninka.org
Results Intraperitoneal PRI-724 injection ameliorates hepatitis C virus-induced liver fibrosis.
To evaluate the anti-fibrotic activity of PRI-724 on liver fibrosis induced by HCV, HCV …
To evaluate the anti-fibrotic activity of PRI-724 on liver fibrosis induced by HCV, HCV …
Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model.
Y Tokunaga, Y Osawa, T Ohtsuki, Y Hayashi… - Scientific …, 2017 - europepmc.org
Chronic hepatitis C virus (HCV) infection is one of the major causes of serious liver
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
[引用][C] Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Y Tokunaga, Y Osawa, T Ohtsuki, Y Hayashi… - Scientific Reports, 2017 - cir.nii.ac.jp
Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced
liver fibrosis in mouse model | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
liver fibrosis in mouse model | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Y Tokunaga, Y Osawa, T Ohtsuki, Y Hayashi… - Scientific …, 2017 - ui.adsabs.harvard.edu
Chronic hepatitis C virus (HCV) infection is one of the major causes of serious liver
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model
Y Tokunaga, Y Osawa, T Ohtsuki… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
Chronic hepatitis C virus (HCV) infection is one of the major causes of serious liver
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model.
Y Tokunaga, Y Osawa, T Ohtsuki, Y Hayashi… - Scientific …, 2017 - europepmc.org
Chronic hepatitis C virus (HCV) infection is one of the major causes of serious liver
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …
diseases, including liver cirrhosis. There are no anti-fibrotic drugs with efficacy against liver …